Entelexo Biotherapeutics

Creating a New Class of Drugs to Address Incurable Autoimmune DiseasesEntelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.

ACTIVE FOUNDERS

Founder 1

MILAD RIAZIFAR,

Dr. Riazifar has worked on stem cells over a decade and on exosomes a subclass of stem cell derived extracellular vesicles since 2012. During his Ph.D studies at the Stem Cell Research Center at the University of California Irvine, he pioneered a cell-free exosome-based approach to treat Multiple Sclerosis. At City of Hope, he was part of a clinical translation team initiating the world’s first clinical trial using stem cell exosomes for the treatment of type I diabetes.

Twitter: | Linkedin: https://www.linkedin.com/in/miladriazifar/

Founder 2

Todd Schurr,

Multidisciplinary engineer with diverse experience in cellular biology, electrical engineering, automotive, and more. To quote Einstein, I am "passionately curious" about just about everything.

Twitter: | Linkedin: https://www.linkedin.com/in/todd-schurr/

Founder 3

Cameron Taylor,

MSE in Biomedical Engineering from University of Michigan, Class of 2018 Co-Founder and CTO at Entelexo Biotherapeutics.

Twitter: | Linkedin: https://www.linkedin.com/in/cameron-taylor-448b5a130/

Founder 4

,

Twitter: | Linkedin:

Founder 5

,

Twitter: | Linkedin:

Founder 6

,

Twitter: | Linkedin: